Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Peipei Xue
T-Lymphokine-Activated Killer Cell-Originated Protein Kinase (TOPK) as a Prognostic Factor and a Potential Therapeutic Target in Glioma
Oncotarget
Oncology
Related publications
T‐lymphokine‐activated Killer Cell‐originated Protein Kinase (TOPK)‐positive Colorectal Tumor Growth Is Suppressed by Acetylshikonin
British Journal of Pharmacology
Pharmacology
Cloning and Expression of a Novel MAPKK-like Protein Kinase, Lymphokine-Activated Killer T-Cell-Originated Protein Kinase, Specifically Expressed in the Testis and Activated Lymphoid Cells
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Mitotic Kinase PBK/TOPK as a Therapeutic Target for Adult T‑cell Leukemia/Lymphoma
International Journal of Oncology
Cancer Research
Oncology
Phosphorylation of IκBα at Serine 32 by T-Lymphokine-Activated Killer Cell-Originated Protein Kinase Is Essential for Chemoresistance Against Doxorubicin in Cervical Cancer Cells
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Smaller Protein, Larger Therapeutic Potential: PPM1D as a New Therapeutic Target in Brainstem Glioma
Pharmacogenomics
Molecular Medicine
Genetics
Pharmacology
Protein Kinase C as a Therapeutic Target
Clinical Cancer Research
Cancer Research
Oncology
peIF4E as an Independent Prognostic Factor and a Potential Therapeutic Target in Diffuse Infiltrating Astrocytomas
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
The Roles of Protein Kinase R in Cancer: Potential as a Therapeutic Target
Cancer Science
Cancer Research
Medicine
Oncology
COL12A1, a Novel Potential Prognostic Factor and Therapeutic Target in Gastric Cancer
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
